Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief
Friday, Apr. 15th 2011 6:24 AM
Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night.
Related posts:
- New Mexico Share of Cost, Disagreement On Symptom-Reflux Association Analysis Parameters In Infants New Mexico Share of Cost, Disagreement On Symptom-Reflux Association Analysis Parameters In Infants: Gastroesophageal reflux (GER), defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease (GERD)....
- NICE Draft Guidance Gives People Living With Hepatitis C More Treatment Options NICE is currently updating part of its guidance on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Reflecting changes in the licensed indications for peginterferon alfa, today’s draft guidance reaffirms the previous draft issued for public consultation in recommending wider use of these drugs, and, where appropriate, shorter treatment […]...
- Medicaid-funded ADHD Treatment For Children Misses The Mark The enactment of the Patient Protection and Affordable Care Act of 2010 expands Medicare benefits to scores of previously uninsured individuals including many of our nation’s children. While access to treatment is laudable, the quality of such treatment is the subject of an article in the December issue of the Journal of the American Academy […]...
- Researchers Find More Evidence That Malaria Drug Could Help Combat Cancer, And That Breaks From Treatment Could Improve Results Scientists investigating the cancer-fighting properties of artesunate a drug commonly used to treat malaria have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels. The findings, recently published in […]...
- Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Oregon Share of Cost, Join Neutrogena’s Wave For Change And Help Raise Up To $200,000 For Disaster Relief, Education And Environmental Charities Oregon Share of Cost, Join Neutrogena’s Wave For Change And Help Raise Up To $200,000 For Disaster Relief, Education And Environmental Charities: Understanding teens’ determination and passion for change, Neutrogena, the #1 dermatologist-recommended skin care brand, is launching Wave for Change, a charitable campaign that makes it easy for teens everywhere to not only give […]...
- Florida Share of Cost, WFP Plans Massive Scale Up In Hunger Relief Operation As Needs Grow Dramatically In Drought-Hit Niger Florida Share of Cost, WFP Plans Massive Scale Up In Hunger Relief Operation As Needs Grow Dramatically In Drought-Hit Niger: The United Nations World Food Programme (WFP) today said it is massively scaling-up its food assistance operation in the west African state of Niger to feed up to 8 million hungry people who have lost […]...
- Michigan Share of Cost, National RN Relief Group Teams Up With Navy For Medical Mission To Haiti Michigan Share of Cost, National RN Relief Group Teams Up With Navy For Medical Mission To Haiti: The first team of registered nurse volunteers from California, Michigan, and Washington State will depart for Haiti Wednesday morning with the Department of Defense’s Continuing Promise, National Nurses United (NNU), the nation’s largest organization of registered nurses, announced. […]...
- New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study: Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTC™ offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing […]...
Posted on Friday, Apr. 15th 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »